Parmax Pharma Ltd.
| BSE: 540359 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE240T01014 |
| BSE 11:34 | 05 Aug | 48.45 |
-0.95 (-1.92%) |
OPEN
49.40 |
HIGH
51.80 |
LOW
46.95 |
| NSE 05:30 | 01 Jan | Parmax Pharma Ltd |
| OPEN | 49.40 |
| PREVIOUS CLOSE | 49.40 |
| VOLUME | 1170 |
| 52-Week high | 81.90 |
| 52-Week low | 24.25 |
| P/E | 23.99 |
| Mkt Cap.(Rs cr) | 18 |
| Buy Price | 48.45 |
| Buy Qty | 47.00 |
| Sell Price | 51.80 |
| Sell Qty | 72.00 |
Parmax Pharma Ltd. (PARMAXPHARMA) - Listing Info
| Key Dates | |
| Year Ending Month | March |
| AGM Date (Month) | Oct |
| Book Closure Date (Month) | Oct |
| Listing Information | |
| Face Value Of Equity Shares | 10 |
| Market Lot Of Equity Shares | 1 |
| BSE Code | 540359 |
| NSE Code | N.A. |
| BSE Group | X |
| Whether The Company Forms A Part Of The Following Indices - | |
| Sensex | No |
| Nifty | No |
| BSE 100 | No |
| BSE 200 | No |
| BSE 500 | No |
| CNX 500 | No |
| CNX Midcap | No |
| Listing On | |
| Listing On | The Stock Exchange, Mumbai Stock Exchange |
Quick Links for Parmax Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
